NCT05232305

Brief Summary

The aim of this study is to evaluate the effects of the consumption of bread produced with the addition of pomegranate peels, which has a high antioxidant content, on blood glucose and lipid parameters, and some oxidant-antioxidant enzymes and lipid peroxidation in individuals with type 2 diabetes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 9, 2022

Completed
20 days until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

February 9, 2022

Status Verified

February 1, 2022

Enrollment Period

1 month

First QC Date

December 9, 2021

Last Update Submit

February 8, 2022

Conditions

Keywords

AntioxidantObesityPomegranate peelOxidationType 2 Diabetes

Outcome Measures

Primary Outcomes (10)

  • Biochemical Blood Parameters

    Examination of between group differences regarding lipid profile

    First day at the beginning of the study

  • Biochemical Blood Parameters

    Examination of between group differences regarding HbA1c

    First day at the beginning of the study

  • Biochemical Blood Parameters

    Examination of between group differences regarding insulin

    First day at the beginning of the study

  • Biochemical Blood Parameters

    Examination of between group differences regarding TAC

    First day at the beginning of the study

  • Biochemical Blood Parameters

    Examination of between group differences regarding TBARS

    First day at the beginning of the study

  • Anthropometric Measurements - Weight

    Examination of between group differences regarding weight in kilogram

    First day at the beginning of the study

  • Anthropometric Measurements - Height

    Examination of between group differences regarding height in meter

    First day at the beginning of the study

  • Anthropometric Measurements - Body Mass Index

    Examination of between group differences regarding body mass index (BMI = weight in kilogram / height in meter 2)

    First day at the beginning of the study

  • Anthropometric Measurements - Waist Circumference

    Examination of between group differences regarding waist circumference in centimeters

    First day at the beginning of the study

  • Anthropometric Measurements - Hip Circumference

    Examination of between group differences regarding hip circumference in centimeters

    First day at the beginning of the study

Secondary Outcomes (10)

  • Biochemical Blood Parameters

    Eight weeks after the start of the study

  • Biochemical Blood Parameters

    Eight weeks after the start of the study

  • Biochemical Blood Parameters

    Eight weeks after the start of the study

  • Biochemical Blood Parameters

    Eight weeks after the start of the study

  • Biochemical Blood Parameters

    Eight weeks after the start of the study

  • +5 more secondary outcomes

Study Arms (2)

People with type 2 diabetes who eat bread with pomegranate crust - Experimental Group

EXPERIMENTAL

Individuals with type 2 diabetes who met the inclusion criteria and participated in the study will divided into two groups by Specialist Akkız Zuhal ÖZTAŞ and Specialist Doctor Emel ŞENOL, and they will be asked to consume the breads produced (in the preliminary study) produced as a standard (n=15) and with the addition of pomegranate peel (n=15) for eight weeks. The individuals participating in the study will be asked not to change their eating habits, physical activity habits, and drug treatments during the study period. Each individual participating in the study will be provided with the required amount of bread during the study and will be contacted weekly by Zeynep ÇAMLIK, a specialist dietitian, to verify whether they consume bread regularly.

Dietary Supplement: Pomegranate Peel

No intervention - Control Group

NO INTERVENTION

Individuals with type 2 diabetes will not eat pomegranate crust bread

Interventions

Pomegranate PeelDIETARY_SUPPLEMENT

Standard bread and test breads (with added pomegranate peel) to be used in the study will be produced by Asst. Prof. Özlem ÖZPAK AKKUŞ in the Nutrition Principles Laboratory of Toros University. For standard bread, 900 ml of water, 42 fresh yeast, 12 g of salt and 12 g of sunflower oil will be added to 1000 g of sifted whole wheat flour and the prepared bread mixture will be divided into 40 equal parts. To make bread with pomegranate peel added, 1000 g of sifted whole wheat flour, 20 g of pomegranate peel powder, 914 ml of water, 42 g of fresh yeast, 12 g of salt and 12 g of sunflower oil will be added and the prepared bread mixture is divided into 40 equal parts with 500 mg of pomegranate peel powder in each piece).

People with type 2 diabetes who eat bread with pomegranate crust - Experimental Group

Eligibility Criteria

Age19 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being diagnosed with type 2 diabetes for at least 5 years,
  • Using only oral antidiabetic
  • With a Body Mass Index (BMI) value ≥ 25.0 kg/m2,
  • Signing the Informed Voluntary Consent Form,
  • Being in an age range of 19-64 years.

You may not qualify if:

  • Having kidney, liver, and inflammatory diseases,
  • Being on insulin therapy,
  • Using prescription drugs and/or fiber supplements,
  • Taking vitamin and mineral supplements,
  • Being pregnant/lactating,
  • Consuming excessive alcohol (\>2 drinks/day),
  • Being in the menstrual period,
  • Receiving gluten enteropathy,
  • Having allergy against pomegranate.
  • In addition, individuals with Covid-19-related condition during the study process will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Özlem ÖZPAK AKKUŞ

Mersin, Yenişehir, 33100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Obesity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participants will not know which type of bread to eat.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study will conduct by using a prospective randomized double-blind clinical trial model.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 9, 2021

First Posted

February 9, 2022

Study Start

March 1, 2022

Primary Completion

April 1, 2022

Study Completion

June 1, 2022

Last Updated

February 9, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

Data can be shared in consultation with the principal investigator.

Time Frame
data can be shared after the research is published in consultation with the principal investigator.
Access Criteria
data can be shared after the research is published in consultation with the principal investigator.

Locations